A 35-year-old, gravida 3, para 2, woman was referred to the hospital at 18 weeks of gestation for amniocentesis because of advanced maternal age and relatives with balanced and unbalanced chromosomal translocations. Her husband and her elder daughter had a balanced translocation of t(2;15)(q37.3;q24.3). Her younger daughter suffered from mental retardation and had an unbalanced translocation of der(2)t(2;15) (q37.3;q24.3)pat. The woman's karyotype was normal. Prenatal ultrasound during the current pregnancy revealed no structural abnormalities. Genetic amniocentesis was performed at 19 weeks of gestation, and 30 mL of amniotic fluid was aspirated, of which 10 mL was used for array comparative genomic hybridization (aCGH) using uncultured amniocytes and 20 mL was used for conventional cytogenetic analysis using cultured amniocytes. Within 3 days, bacterial artificial chromosome (BAC)-based aCGH demonstrated partial monosomy 2q and partial trisomy 15q [arr cgh 2q37.3q37.3 (RP11-299F2 RP11-875C22) × 1, 15q25.1q26.3 (RP11-10K12 RP11-530H6) × 3] (Figure 1 ). Conventional cytogenetic analysis revealed
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Comparative genomic hybridization (CGH) and BAC-based and oligonucleotide-based aCGH using cultured or uncultured amniocytes have been successfully applied for the prenatal diagnosis of chromosome abnormalities [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . CGH and aCGH have the advantage of providing a rapid genome-wide study without the need for cell culture but the disadvantage of an inability to detect low-level mosaicism, balanced translocations, inversions, and polyploidy. Genomewide association studies also provide insight into our understanding of diseases, as well as rapid diagnosis of uniparental disomy [12, 13] . CGH and aCGH have been shown to be valuable alternatives to interphase fluorescence in situ hybridization for the rapid prenatal detection of unbalanced chromosomal abnormalities in uncultured amniocytes. Lapierre et al [1] first reported the clinical analysis of uncultured amniocytes by CGH in 71 amniotic fluid samples, of which 66 (93%) had informative results, five (7%) had uninformative results; seven trisomies (trisomy 13 (11) (p13q21), inv(9) (p11q13), and inv(Y) (p11.1q11.22)] were not detected. In a study of 30 uncultured prenatal samples from chorionic villi or 1-2 mL of uncultured amniotic fluid using aCGH, Rickman et al [3] found that 29 of 30 samples were correctly diagnosed, with the exception of one sample with triploidy. They also found that aCGH was able to detect aneuploidy in DNA isolated from as little as 1 mL of uncultured amniotic fluid. In a study of 98 pregnancies (56 amniotic fluid and 42 chorionic villus sampling specimens), Sahoo et al [4] demonstrated complete concordance between conventional karyotyping and BAC-aCGH results, including five positive cases with chromosomal abnormalities. BAC-aCGH results were available within an average of 6 days for uncultured cells and 16 days for cultured cells. In a study of 15 amniotic fluid samples from pregnancies of 15-22 weeks of gestation, Bi et al [7] extracted DNA from 5-10 mL of amniotic fluid for whole genome amplification using oligonucleotidebased aCGH and found that the results of aCGH were consistent with those of chromosome analysis. The authors obtained high-quality aCGH results using oligonucleotide-based aCGH in 86.7% (13/15) of the samples. They found that a shorter amniotic fluid storage time and a gestational age greater than 17 weeks yielded sufficient (> 300 ng) DNA from the uncultured amniocytes. maternal plasma. Larrabee et al [15] demonstrated that CGH microarray analysis using cell-free fetal DNA in amniotic fluid supernatant could correctly identify fetal sex and aneuploidies such as trisomy 21 (n = 3) and 45,X (n = 1). In a study of molecular karyotyping using BAC-aCGH and cell-free fetal DNA in 10 mL of amniotic fluid supernatant from nine test amniotic fluid samples, including trisomy 13 (n = 1), trisomy 18 (n = 3), trisomy 21 (n = 2), trisomy 9 mosaicism (90%) (n = 1), 69,XXY (n = 1) and 45,X (n = 1), Lapaire et al [16] found concordant results in eight of the nine cases, with the exception of one case with triploidy, and suggested that cell-free fetal DNA from amniotic fluid supernatant could be analyzed using aCGH to correctly identify human chromosome abnormalities.
In conclusion, we have presented the results of prenatal diagnosis of an unbalanced translocation by aCGH using uncultured amniocytes. This case demonstrates that aCGH can be used for the prenatal diagnosis of chromosomal abnormalities via a standard reproducible procedure that can produce reliable results in a short period of time. 
